Empty Capsule Market
Empty Capsule Industry to Reach USD 9.71 Billion by 2034 as Demand for Advanced Oral Dosage Forms Expands
According to a report published by OG Analysis, the Empty Capsule Market was valued at USD 4.57 billion in 2025 and is projected to reach USD 9.71 billion by 2034, expanding at a CAGR of 9.87%. Growth is supported by pharmaceutical and nutraceutical production, demand for convenient oral dosage forms, and increasing adoption of vegetarian capsule materials.
Market Overview
Empty capsules are hard shells used to contain medicines, dietary supplements, vitamins, botanicals and specialty formulations. Gelatin capsules remain widely used, while non-gelatin alternatives such as hydroxypropyl methylcellulose (HPMC) and pullulan are gaining traction. Buyers prioritize consistent dimensions, reliable performance on automated filling lines, material compatibility, stability, regulatory documentation and dependable supply. Innovation focuses on low-moisture designs, barrier performance, modified-release delivery and customization for brand identification.
Key Market Insights
• The market was valued at USD 4.57 billion in 2025 and is forecast to reach USD 9.71 billion by 2034, at a CAGR of 9.87%.
• Pharmaceutical and nutraceutical manufacturers are major customers, with CDMOs contributing to demand for consistent, high-volume supply.
• Vegetarian and non-gelatin capsules are gaining adoption owing to dietary preferences and formulation stability needs.
• Low-moisture capsules are increasingly relevant for probiotics, enzymes and other sensitive ingredients.
• Capsule printing, color customization and traceability support differentiation and brand protection.
Market Dynamics
• Expanding consumption of vitamins, botanical supplements and functional ingredients increases demand for flexible oral dosage formats.
• Generic drug production and pharmaceutical outsourcing support volume growth and supplier standardization.
• HPMC and other plant-based capsules are benefiting from clean-label positioning and compatibility with moisture-sensitive fills.
• Higher-speed filling equipment increases the importance of dimensional consistency, low breakage rates and technical support.
• Specialty applications encourage innovation in delayed-release, sustained-release and capsule-in-capsule formats.
• Challenges include raw-material cost volatility, strict quality audits, supply-chain concentration and the need to balance price with performance.
Browse for More Information
https://www.oganalysis.com/industry-reports/empty-capsule-market
Market Segmentation
By Type: Gelatin Capsules; Non-Gelatin Capsules. By Functionality: Immediate-release Capsules; Sustained-release Capsules; Delayed-release Capsules. By Application: Antibiotic and Antibacterial Drugs; Dietary Supplements; Antacid and Antiflatulent Preparations; Antianemic Preparations; Anti-inflammatory Drugs; Cardiovascular Therapy Drugs; Cough and Cold Drug Preparations; Other Therapeutic Applications. By End-User: Pharmaceutical Industry; Nutraceutical Industry; Cosmetic Industry; Research Laboratories. Geographic coverage spans North America, Europe, Asia-Pacific, Middle East & Africa, and South & Central America.
Regional Insights
• North America: Strong supplement consumption, pharmaceutical production and CDMO activity support demand for reliable and specialty capsule solutions.
• Europe: Regulatory requirements, mature pharmaceutical manufacturing and preference for vegetarian and sustainably sourced products shape purchasing decisions.
• Asia-Pacific: Large-scale pharmaceutical manufacturing, rising domestic supplement consumption and expanding plant-based capsule capacity drive opportunities.
• Middle East & Africa: Demand is supported by supplement growth, local manufacturing initiatives and interest in halal-friendly or vegetarian options.
• South & Central America: Expanding supplement brands and pharmaceutical production create opportunities for affordable, quality-assured capsule supply.
Competitive Landscape
Competition reflects manufacturing scale, quality systems, regulatory audit readiness, consistent capsule machinability, material innovation, technical service and secure lead times. Leading and specialist suppliers compete across standard gelatin shells, plant-based capsules, and high-performance formulations. Companies identified by OG Analysis include Lonza Group, ACG Worldwide, Qualicaps, Suheung Co. Ltd., CapsCanada Corporation, Bright Pharma Caps, Medi-Caps Ltd, Natural Capsules Limited, Anhui Huangshan Capsule Co. Ltd., Snail Pharma Industry Co. Ltd., Shangxi JC Biological Technology Co. Ltd, Rottendorf Pharma and Gelita AG.
Industry Developments
• Manufacturers are expanding plant-based capsule offerings to address dietary requirements and stability needs.
• Product engineering increasingly emphasizes reduced brittleness, lower moisture levels and improved high-speed filling performance.
• Customization through colors, printed identifiers and traceability features is becoming more important for brand differentiation.
• Pharmaceutical and CDMO buyers increasingly prioritize audited suppliers, multi-site manufacturing and supply continuity.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Игры
- Gardening
- Health
- Главная
- Literature
- Music
- Networking
- Другое
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness